Certainly that would be the case. There will still be a private sector payment for prescription drugs even after pharmacare, because pharmacare obviously is not going to cover everything. There will be a division between the costs in terms of what the public sector is paying and what the private sector is paying. Whether there will be some kind of savings here in that process that can be used by the federal government is a question that has to be asked.
On September 29th, 2016. See this statement in context.